Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors

References

• Brocklehurst K, Willenbrock F, Salih E. In: Neuberger A, Brocklehurst K, eds. New comprehensive biochemistry. Amsterdam: Elsevier; 1987;16:39–158.
   Google Scholar
• Hedstrom L. Serine protease mechanism and specificity. Chem Rev 2002;102:4501–23.
   PubMed Web of Science ®Google Scholar
• Rawling ND, Morton FR, Kok CY, et al. MEROPS: the peptidase database. Nucleic Acids Res 2007;36:D320–5.
   PubMed Web of Science ®Google Scholar
• Perera NC, Schilling O, Kittel H, et al. NSP4, an elastase-related protease in human neutrophils with arginine specificity. Proc Natl Acad Sci USA 2012;109:6229–34.
   PubMed Web of Science ®Google Scholar
• Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 2010;62:726–59.
   PubMed Web of Science ®Google Scholar
• Heutinck KM, ten Berge IJ, Hack CE, et al. Serine proteases of the human immune system in health and disease. Mol Immunol 2010;47:1943–55.
   PubMed Web of Science ®Google Scholar
• Bardoel BW, Kenny EF, Sollberger G, Zychlinsky A. The balancing act of neutrophils. Cell Host Microbe 2014;15:526–36.
   PubMed Web of Science ®Google Scholar
• Sinha S, Watorek W, Karr S, et al. Primary structure of human neutrophil elastase. Proc Natl Acad Sci USA 1987;84:2228–32.
   PubMed Web of Science ®Google Scholar
• Chua F, Laurent GJ. Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc 2006;3:424–7.
   PubMedGoogle Scholar
• Pham CT. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 2006;6:541–50.
   PubMed Web of Science ®Google Scholar
• Stapels DA, Geisbrecht BV, Rooijakkers SH. Neutrophil serine proteases in antibacterial defense. Curr Opin Microbiol 2015;23:42–8.
   PubMed Web of Science ®Google Scholar
• Saitoh T, Komano J, Saitoh Y, et al. Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. Cell Host Microbe 2012;12:109–16.
   PubMed Web of Science ®Google Scholar
• Fitch PM, Roghanian A, Howie SEM, Sallenave J-M. Human neutrophil elastase inhibitors in innate and adaptive immunity. Biochem Soc Trans 2006;34:279–82.
   PubMed Web of Science ®Google Scholar
• Janciauskiene SM, Bals R, Koczulla R, et al. The discovery of α1-antitrypsin and its role in health and disease. Respir Med 2011;105:1129–39.
   PubMed Web of Science ®Google Scholar
• Quabius ES, Görögh T, Fischer GS, et al. The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma. Cancer Lett 2015;357:339–45.
   PubMed Web of Science ®Google Scholar
• Zhong QQ, Wang X, Li YF, et al. Secretory leukocyte protease inhibitor promising protective roles in obesity-associated atherosclerosis. Exp Biol Med 2017;242:250–7.
   Web of Science ®Google Scholar
• Zani M-Z, Nobar SM, Lacour SA, et al. Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris. Eur J Biochem 2004;271:2370–8.
   PubMedGoogle Scholar
• Kawabata K, Hagio T, Matsuoka S. The role of neutrophil elastase in acute lung injury. Eur J Pharmacol 2002;451:1–10.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Stockley RA. COPD: current therapeutic interventions and future approaches. Eur Respir J 2005;25:1084–106.
   PubMed Web of Science ®Google Scholar
• Pandey KC, De S, Mishra PK. Role of proteases in chronic obstructive pulmonary disease. Front Pharmacol 2017;8:512–9.
   PubMed Web of Science ®Google Scholar
• Kelly E, Greene CM, McElvaney NG. Targeting neutrophil elastase in cystic fibrosis. Expert Opin Ther Targets 2008;12:145–57.
   PubMed Web of Science ®Google Scholar
• Wagner CJ, Schultz C, Mall MA. Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease. Mol Cell Pediatr 2016;3:25.
   PubMedGoogle Scholar
• Hilbert N, Schiller J, Arnhold J, Arnold K. Cartilage degradation by stimulated human neutrophils: elastase is mainly responsible for cartilage damage. Bioorg Chem 2002;30:119–32.
   PubMed Web of Science ®Google Scholar
• Henriksen PA, Sallenave J-M. Human neutrophil elastase: mediator and therapeutic target in atherosclerosis. Int J Biochem Cell Biol 2008;40:1095–100.
   PubMed Web of Science ®Google Scholar
• Dhanrajani PJ. Papillon–Lefevre syndrome: clinical presentation and a brief review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:e1–7.
   PubMed Web of Science ®Google Scholar
• Cools-Lartigue J, Spicer J, Najmeh S, Ferri L. Neutrophil extracellular traps in cancer progression. Cell Mol Life Sci 2014;71:4179–94.
   PubMed Web of Science ®Google Scholar
• Lucas SD, Costa E, Guedes RC, Moreira R. Targeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase. Med Res Rev 2013;33:E73–101.
   PubMed Web of Science ®Google Scholar
• Tsai Y-F, Hwang T-L. Neutrophil elastase inhibitors: a patent review and potential applications for inflammatory lung diseases (2010–2014). Expert Opin Ther Pat 2015;25:1145–58.
   PubMed Web of Science ®Google Scholar
• Tebbutt SJ. Technology evaluation: transgenic alpha-1-antitrypsin (AAT), PPL therapeutics. Curr Opin Mol Ther 2000;2:199–204.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society/European Respiratory Society Statement, Standards for the diagnosis and management of individual with alpha-1-antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818–900.
   PubMed Web of Science ®Google Scholar
• Von Nussbaum F, Li VMJ. Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: into clinical testing with pre-adaptive pharmacophores. Bioorg Med Chem 2015;25:4370–81.
   Web of Science ®Google Scholar
• Ohbayashi H. Current synthetic inhibitors of human neutrophil elastase in 2005. Expert Opin Ther Pat 2005;15:759–71.
   Web of Science ®Google Scholar
• Iwata K, Doi A, Ohji G, et al. Effect of neutrophil elastase inhibitor (Sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress (ARDS): a systemic review and meta-analysis. Intern Med 2010;49:2423–32.
   PubMed Web of Science ®Google Scholar
• Stockley R, De Soyza A, Gunawardena K, et al. Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis. Respir Med 2013;107:524–33.
   PubMed Web of Science ®Google Scholar
• Von Nussbaum F, Li VMJ, Allerheiligen S, et al. Freezing the bioactive conformation to boost potency: the identification of BAY 85-8501, a selective and potent inhibitor of human neutrophil elastase for pulmonary diseases. ChemMedChem 2015;10:1163–73.
   PubMed Web of Science ®Google Scholar
• Crocetti L, Giovannoni MP, Schepetkin IA, et al. Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase. Bioorg Med Chem 2011;19:4460–72.
   PubMed Web of Science ®Google Scholar
• Crocetti L, Schepetkin IA, Cilibrizzi A, et al. Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase. J Med Chem 2013;56:6259–72.
   PubMed Web of Science ®Google Scholar
• Crocetti L, Schepetkin IA, Ciciani G, et al. Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors. Drug Dev Res 2016;77:285–99.
   PubMed Web of Science ®Google Scholar
• Giovannoni MP, Schepetkin IA, Crocetti L, et al. Cinnoline derivatives as human neutrophil elastase inhibitors. J Enzyme Inhib Med Chem 2016;31:628–39.
   PubMed Web of Science ®Google Scholar
• Vergelli C, Schepetkin IA, Crocetti L, et al. Isoxazol-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors. J Enzyme Inhib Med Chem 2017;32:821–31.
   PubMed Web of Science ®Google Scholar
• Beccalli EM, Marchesini A. The Vilsmeier–Haack reaction of isoxazoline-5-ones. Synthesis and reactivity of 2-(dialkylamino)-1,3-oxazin-6-ones. J Org Chem 1987;52:3426–34.
   Web of Science ®Google Scholar
• Breslow T, Eicher A, Krebs RA, et al. Diphenylcyclopropenone. J Am Chem Soc 1965;87:1320–5.
   Web of Science ®Google Scholar
• Boulton AJ, Katritzky AR. The tautomerism of heteroaromatic compounds with five-membered rings-I: 5-hydroxyisoxazoles-isoxazol-5-ones. Tetrahedron 1961;12:41–50.
   Web of Science ®Google Scholar
• Batra S, Bhaduri AP. An account of the chemistry of 3,4-disubstituted 5-isoxazolones. J Indian Inst Sci 1994;74:213–26.
   Google Scholar
• Safi R, Rodriguez F, Hilal G, et al. Hemisynthesis, antitumoral effect, and molecular docking studies of ferutinin and its analogues. Chem Biol Drug Des 2016;87:382–97.
   PubMed Web of Science ®Google Scholar
• Onoda A, Yamada Y, Nakayama Y, et al. Stabilization of calcium- and terbium-carboxylate bonds by NH····O hydrogen bonds in a mononuclear complex. A functional model of the active site of calcium-binding proteins. Inorg Chem 2004;43:4447–55.
   PubMed Web of Science ®Google Scholar
• Belzecki C, Urbanski T. New antituberculosis agents. XXXVII. Thiosemicarbazones of oxo acids. 2. Thiosemicarbazones of aroyl fatty acids. Roczniki Chemii 1958;32:769–78.
   Google Scholar
• Cadieux JA, Zhang Z, Mattice M, et al. Synthesis and biological evaluation of substituted pyrazoles as blockers of divalent metal transporter 1 (DMT1). Bioorg Med Chem Lett 2012;22:90–5.
   PubMed Web of Science ®Google Scholar
• Xie X, Cai G, Ma D. CuI/L-proline-catalyzed coupling reactions of aryl halides with activated methylene compounds. Org Lett 2005;7:4693–5.
   PubMed Web of Science ®Google Scholar
• Monastyrskyi A, Namelikonda NK, Manetsch R. Metal-free arylation of ethyl acetoacetate with hypervalent diaryliodonium salts: an immediate access to diverse 3-aryl-4(1H)-quinolones. J Org Chem 2015;80:2513–20.
   PubMed Web of Science ®Google Scholar
• Wierenga W, Evans BR, Zurenko G. Benzisoxazolones: antimicrobial and antileukemic activity. J Med Chem 1984;27:1212–5.
   PubMed Web of Science ®Google Scholar
• Forist AA, Weber DJ. Kinetics of hydrolysis of hypoglycemic 1-acyl 3,5-dimethylpyrazoles. J Pharm Sci 1973;62:318–9.
   PubMed Web of Science ®Google Scholar
• Accelrys Software Inc., San Diego, CA 92121, USA.
   Google Scholar
• Brooks BR, Bruccoleri RE, Olafson BD, et al. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 1983;4:187–217.
   Web of Science ®Google Scholar
• Gaussian 09, Revision C.01, Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA, Jr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Keith T, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas O, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ, Gaussian, Inc., Wallingford CT, 2010.12.
   Google Scholar
• Becke AD. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev 1988;38:3098–100.
   Web of Science ®Google Scholar
• Vosko SH, Wilk L, Nusair M. Accurate spin-dependent electron liquid correlation energies for local spin density calculations: a critical analysis. Can J Phys 1980;58:1200–11.
   Web of Science ®Google Scholar
• Grimme SJ. Semiempirical GGA-type density functional constructed with a long-range dispersion correction. J Comput Chem 2006;27:1787–99.
   PubMed Web of Science ®Google Scholar
• Hehre WJ, Ditchfield R, Pople JA. Self-consistent molecular orbital methods. XII. Further extensions of Gaussian-type basis sets for use in molecular orbital studies of organic molecules. J Chem Phys 1972;56:2257–61.
   Web of Science ®Google Scholar
• Peng C, Ayala PY, Schlegel HB, Frisch MJ. Using redundant internal coordinates to optimize equilibrium geometries and transition states. J Comput Chem 1996;17:49–56.
   Web of Science ®Google Scholar
• Dassault Systèmes BIOVIA, Discovery Studio Visualizer, Release 4.5, San Diego: Dassault Systèmes; 2015.
   Google Scholar
• Katritzky AR, Barczynski P, Ostercamp DL, Yousaf TI. Mechanisms of heterocyclic ring formations. 4. A 13C-NMR study of the reaction of β-keto esters with hydroxylamine. J Org Chem 1986;51:4037–42.
   Web of Science ®Google Scholar
• Laufer SA, Margutti S. Isoxazolone based inhibitors of p38 MAP kinases. J Med Chem 2008;51:2580–4.
   PubMed Web of Science ®Google Scholar
• Franchini PF. Dipole moments and tautomerism of isoxazolin-5-ones. Corsie Sem Chim 1968;14:23–5.
   Google Scholar
• Cencioni R, Franchini PF, Orienti M. Dipole moments of 5-substitued isoxazoles. I. Dipole moments and tautomerism of isoxazolin-5-one. Tetrahedron 1968;24:151–66.
   Web of Science ®Google Scholar
• Elguero J, Marzin C, Katritzky AR, Linda P, eds. Advances in heterocyclic chemistry, supplement 1, the tautomerism of heterocycles. New York: Academic Press; 1976:656.
   Google Scholar
• Frolund B, Jensen LS, Guandalini L, et al. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABAA antagonists: synthesis, pharmacology, and molecular modeling. J Med Chem 2005;48:427–39.
   PubMed Web of Science ®Google Scholar
• Nishiwaki N, Nogami T, Kawamura T, et al. One-pot synthesis of polyfunctionalised isoxazol(in)es. J Org Chem 1999;64:6476–8.
   Web of Science ®Google Scholar
• Allen FH. The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Crystallogr B 2002;58:380–8.
   PubMed Web of Science ®Google Scholar
• Navia MA, McKeever BM, Springer JP, et al. Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84 Å resolution. Proc Natl Acad Sci USA 1989;86:7–11.
   PubMed Web of Science ®Google Scholar
• Schepetkin IA, Khlebnikov AI, Quinn MT. N-benzoylpyrazoles are novel small-molecule inhibitors of human neutrophil elastase. J Med Chem 2007;50:4928–38.
   PubMed Web of Science ®Google Scholar